The gastric electrical stimulator market is poised for significant growth over the next decade. Estimated to be valued at USD 240.6 million in 2023, the market is projected to expand at a robust compound annual growth rate (CAGR) of 6.1% from 2023 to 2033, reaching an anticipated value of approximately USD 433.8 million by the end of the forecast period.
Gastric electrical stimulators (GES) are medical devices designed to manage chronic gastrointestinal conditions, particularly gastroparesis, by delivering electrical pulses to the stomach muscles to stimulate motility and alleviate symptoms.
Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4044
Key Takeaway:
- The global gastric electrical stimulator market is expected to reach US$433.8 million by 2033, growing at a CAGR of 6.1% from its 2023 valuation of US$240.6 million.
- Advancements in high-frequency stimulators and their effectiveness in managing chronic conditions like gastroparesis are key growth drivers.
The Dynamic Landscape:
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interests of potential buyers and create a larger customer base. For instance,
- IntraPace Inc. was established in 2001 to address an unmet need in weight loss surgery by continuing to develop a gentler solution. The company is focusing on gastric pacing devices that use electrical stimulation to influence gut contractions.
Key Developments
- Medtronic teamed up with Google, a leader in artificial intelligence, to use AI to improve gastric electrical stimulators. This partnership aims to create a cutting-edge stimulator that can adjust to the needs of each patient, potentially revolutionizing the effectiveness and personalization of treatment.
- The INSPIRIS Control wireless stomach electrical stimulator, introduced by IntraPace in 2021, represented a significant advance in patient-centered technology. This wireless technology offers a more practical and patient-friendly alternative by not requiring invasive surgery for installation or removal, potentially changing the face of stomach electrical stimulation therapy.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-4044
Key Companies Profiled:
- Medtronic Plc.
- IntraPace Inc.
- ReShape Lifesciences Inc.
- Changzhou Ruishen Medical Equipment Co. Ltd.
- Chentao Medical Equipment
- Rishena Co. Ltd.
- Enterra TM
Key Segments of Gastric Electrical Stimulators Industry Survey:
By Type:
- High Frequency
- Low Frequency
By Application:
- Gastroparesis
- Obesity
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Other End Users
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East & Africa
Secure Your Market Analysis Now: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/4044
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
